| JXSS2200037 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-11-21 | | | | | view |
| JYSB2300064 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-04-14 | | | | | view |
| JYSB2300041 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-04 | | | | | view |
| JYSB2200190 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2022-10-10 | | | | | view |
| JYSB1400053 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2014-03-27 | | | Certificate Issued | 2015-12-11 | view |
| JXSL0800044 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Import Drug Application | 2008-12-02 | Roche Pharma (Schweiz) Ltd | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2010-05-26 | view |
| CXSS2300005 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-02-07 | | Hisun Biopharmaceutical Co Ltd | | | view |
| JYSB2000406 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | | | Filed | 2020-09-01 | view |
| JYSZ1700014 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2017-08-16 | | | Certificate Issued | 2017-10-31 | view |
| JXSS1000011 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Import Drug Application | 2010-09-21 | Roche Pharma (Schweiz) Ltd. | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2013-04-03 | view |
| CYSB2400109 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-09 | | Bio-Thera Solutions Ltd | | | view |
| JYSZ2200007 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | License Renew | 2022-02-09 | | | | | view |
| JYSB1800310 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2019-03-27 | | | Certificate Issued | 2019-07-08 | view |
| JYSB1300210 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2013-10-21 | | | Certificate Issued | 2014-06-19 | view |
| JYSB2200158 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2022-08-23 | | | | | view |
| JYSB2000343 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2020-07-08 | | | Certificate Issued | 2020-10-19 | view |
| JXSL0900067 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Import Drug Application | 2009-08-28 | Roche Pharma (Schweiz) Ltd. | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2010-12-28 | view |
| JYSB2300052 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-14 | | | | | view |
| JYSB2000434 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2020-09-07 | | | In Review | 2020-09-04 | view |
| JYSB1800021 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2018-02-07 | | | Certificate Issued | 2019-11-21 | view |
